Omico

22/05/2026

Our recent Omico Town Hall happened to fall on ☕️

Every few weeks, our team comes together for a Town Hall - connecting people across clinical programs, operations, partnerships, data, technology, finance and communications to stay aligned around the work we’re doing.

💙 These touchpoints matter. They help strengthen teamwork, transparency and shared purpose across our national precision oncology programs, and keep patients at the centre of what we do.

Today’s meeting just happened to include a few extra cups of tea. ☕️

20/05/2026

👀 Curious to know more?

Our newsletter shares updates on Omico’s research, initiatives, partnerships and progress — all focused on making precision oncology more accessible for Australians with cancer.

Subscribe and stay informed to the latest from Omico:
👉 https://www.omico.com.au/webform/

There’s always something new happening in precision oncology.

20/05/2026

The newest precision oncology treatments are almost always first accessed through clinical trials.

For Australians facing advanced, incurable or poor prognosis cancer, access to biomarker-led clinical trials can open the door to additional treatment options tailored to the biology of their cancer, with the potential to improve patient outcomes.

That’s why Omico’s * initiative combines comprehensive genomic profiling (CGP), treatment matching and a national clinical trials network, helping identify relevant precision oncology trials that may be suitable for individual patients.
*Precision Oncology Screening Platform Enabling Clinical Trials

On , we acknowledge the patients, clinicians, researchers and industry partners helping drive progress in cancer care and expanding access to precision oncology clinical trials.

Explore how Omico’s program works: https://omico.org.au/our-programs/cancer-screening-program-casp/

18/05/2026

Cancer affects almost every family in some way.

This public event offers the chance to better understand how cancer care is changing—from earlier detection to more personalised treatments—and what these scientific breakthroughs could mean for the future.

Free, in-person event on 28 May, open to everyone.
To register: https://lnkd.in/d5sRiVH4

Cancer is changing. But so is the way we find and fight it.

Medical advances and new technologies are transforming how we detect and treat cancer, but how do we ensure these changes benefit everyone?

Join us for Cancer Reimagined: The Future of Precision Care, an evening exploring the innovations reshaping cancer care, and what it takes to turn scientific breakthroughs into better, more equitable health outcomes for all.

Register to attend: https://www.eventbrite.com.au/e/cancer-reimagined-the-future-of-precision-care-tickets-1985115230091?aff=MedMeta

Australian Research Centre for Cancer Survivorship, Cancer Institute NSW, UNSW AI Institute

14/05/2026

Cancer care is changing, fast.

But turning scientific breakthroughs into real-world outcomes for patients is the work that matters.

Who benefits?
And how do we make sure it’s not just for some, but for everyone?

Free, in-person event on 28 May, open to everyone.
To register: https://www.eventbrite.com.au/e/cancer-reimagined-the-future-of-precision-care-tickets-1985115230091?aff=MedLI

Cancer is changing. But so is the way we find and fight it.

Medical advances and new technologies are transforming how we detect and treat cancer, but how do we ensure these changes benefit everyone?

Join us for Cancer Reimagined: The Future of Precision Care, an evening exploring the innovations reshaping cancer care, and what it takes to turn scientific breakthroughs into better, more equitable health outcomes for all.

Register to attend: https://www.eventbrite.com.au/e/cancer-reimagined-the-future-of-precision-care-tickets-1985115230091?aff=MedMeta

Australian Research Centre for Cancer Survivorship, Cancer Institute NSW, UNSW AI Institute

12/05/2026

Continued access to precision oncology via PrOSPeCT—secured.

More time. More options. More certainty.

That’s what this Federal Budget decision means for Australians facing advanced and incurable cancer.

$71 million has been committed to continue PrOSPeCT through to 2028/29, ensuring access for 25,000 additional Australians to comprehensive genomic profiling and treatment matching, at no cost.

On behalf of patients and families, we congratulate the Government on this important investment.

Learn more: https://omico.org.au/news/federal-government-commits-71m-to-life-extending-precision-oncology/



Cancer Institute NSW Cancer Council Australia Love Your Sister Rare Cancers Australia

12/05/2026

The role of a cancer nurse extends far beyond clinical care.

Compassionate, dedicated, experts—they are indispensable as they guide patients and their loved ones through complex treatments, coordinate care, and provide continuity at every stage.

🩵 Thank you to all cancer nurses this

Cancer Nurses Society of Australia - CNSA Cancer Institute NSW Children's Cancer Institute

11/05/2026

At 29, Nathan was diagnosed with bowel cancer.

📰 The Sun-Herald recently shared his story - an example of what precision oncology can make possible.

Through Omico’s Cancer Screening Program (CaSP), Nathan underwent comprehensive genomic profiling (CGP) and treatment matching. CGP identified a biomarker in his cancer that was not identified through standard testing, enabling his clinician to match him to a therapy that would otherwise not have been considered - treatment that has since helped him become cancer-free.

💙 Today, he is working full-time, and he and his wife are expecting their first child.

For people with incurable or advanced cancer, this matters.
Omico's programs provide access to CGP and treatment matching at no cost, helping identify therapies and clinical trials matched to the biology of a patient’s cancer, options that may otherwise remain unknown.

This is what precision oncology can make possible.
The next step is making this approach routine for all who can benefit, not the exception.



Main photo credit: Wolter Peeters, Sydney Morning Herald.

08/05/2026

💙 is about looking out for each other.

In cancer care, that means access to the most effective options available.

Through Omico, Australians with advanced cancer are accessing comprehensive genomic profiling (CGP) and treatment matching, helping identify what’s driving their cancer and connect them to therapies and clinical trials.

Without this approach, many of these options may remain unknown or out of reach.

It’s already making a difference.
The next step is making it routine, not the exception.

28/04/2026

🩵 Not all superheroes wear capes.

🔹️Some read genomic data.
🔹️Some connect patients to clinical trials and precision treatments.
🔹️Some provide care to people facing cancer.
🔹️Some build the evidence that helps guide decisions.
🔹️Some shape policy and funding that make access possible.
🔹️Some support loved ones through it all.
🔹️Some take part in research, advancing what’s possible.
🔹️Some are in the fight of their lives.

Cancer is one of the leading causes of death in Australia, and the leading cause of death for Australians under 75*.

Changing that takes more than a single breakthrough, or a single group.
It takes collective effort — across clinicians, researchers, policymakers, governments, patients, families and the broader cancer community.

Because progress doesn’t happen in isolation. It happens when all of these roles come together, to expand options, improve outcomes, and bring the advances of precision oncology to the people who need them.

🩵 That’s how cancer meets its match.



*Source: Australian Institute of Health and Welfare.

24/04/2026

🤝 Partnerships are what make progress possible in cancer care.

Recent media coverage in regional Victoria highlights how collaboration between Grampians Health and Omico is helping bring genomic profiling, treatment matching and clinical trial access closer to home.

As Grampians Health Chief Medical Officer, Professor Matthew Hadfield, shared:
💬 “Precision medicine is transforming how we treat cancer, and this program is making sure regional Victorians don’t miss out. By working with Omico, we can provide access to world-class, personalised treatments and innovative clinical trials closer to home, alleviating the need to travel to the city and reducing the stress and burden on patients and their families.

💜 Grampians Health is helping its community better understand precision oncology, while contributing to Omico’s national initiative to expand access and benefit patients across Australia.

You may have heard the recent interview on 3BA radio in Ballarat, and the story also featured in the Golden Plains Times

📰 Newspaper coverage: https://timesnewsgroup.com.au/goldenplains/news/health-services-cancer-care-evolves/